Share on
CONTACT US: 1.800.301.5033


The Benefits of Flexible, Decentralized Trial Designs — And How to Make Them Happen

Clinical trial managers have used digital technology for several years to some degree. Now, because of the pandemic, digital technology has become a proven and valuable necessity. However, for all the benefits of bring your own device (BYOD), electronic patient-reported outcomes (ePRO), and direct data capture (DDC), historically, design and implementation challenges have hindered widespread adoption.

This article was written by Jonathan Andrus, Chief Strategy Officer, at Clinical Ink to appear in the June 2021 issue of PharmaVOICE.

Download and Read This Resource Now